This interactive discussion featured Harry Glorikian, author of MoneyBall Medicine joined by Ülo Palm, Thomas Bock, and Lixia Wang discussing their current work and future outlook along with the important work that The APANDEMIC Initiative has set out to do.
Who can attend
Dial-in available? (listen only)
The definition of RWE
Examples of companies that are effectively working with biopharma to ensure that RWD is thoughtfully collected and analyzed to turn it into a powerful tool
The ability of RWE to predict future pandemics
Challenges to adoption
The potential over reliance on p-values
RCT’s (random clinical trials) limitations on drug efficacy in big populations
Working with regulators
Hosted By AI in Biopharma
We connect the industry’s science minds, AI technology experts, technologists, and strategy leaders through in-person and virtual events and digital content.
Our large community of industry leaders are passionate about the work they do and are dedicated to working at the intersection of science and technology. We collaborate with our industry experts to convene engaged discussions and facilitate the translation of AI/ML technologies into patient impact.